Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Discover which Dividend Etf ranks lowest in fees with a quick fee-focused comparison. Find affordable options and learn how expense ratios affect your returns.
21,760 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Microsoft shares fell Tuesday as investors reassessed the cost of OpenAI bets and growing capital needs, even after a...
Federal health officials issued a warning about misleading statements from biotech billionaire Patrick Soon-Shiong re...
Insmed disclosed that Japan now hosts more MAC lung disease patients than the United States, a development that could...
New SSA data shows benefits rise with age, peaking after delaying retirement credits. But even at 70, many retireesSt...
A rural Louisiana parish is undergoing a dramatic shift as Meta nears completion of a sprawling data center. The proj...
The Baupost founder made a bold, selective move: trim a large Alphabet stake and pivot to a fintech name that slumped...
Across wealth brackets, meme coins are more than a joke. This guide explains why some millionaire investors dabble in...
A branding blitz in national institutions and currency could quietly shift how you plan your money. This article brea...
AI infrastructure is booming, but the real edge sits in data-center networking. This article explains the reason Aris...
Red Cat Holdings posted a record Q4 revenue of $26.2 million and full-year $40.7 million, but margins stayed thin and...
Argan stock ascended today as investors cheered stronger profits and a brighter outlook for energy infrastructure tie...